CIHR invests in New Investigator Grants in Maternal, Reproductive, Child and Youth Health (2017)
The CIHR Institute of Human Development, Child and Youth Health (IHDCYH) in partnership with the Institute of Aboriginal Peoples’ Health (IAPH); Institute of Cancer Research (ICR); Institute of Circulatory and Respiratory Health (ICRH); Institute of Musculoskeletal Health and Arthritis (IMHA); Institute of Neurosciences, Mental Health and Addiction (INMHA); and Institute of Nutrition, Metabolism and Diabetes (INMD) is pleased to announce an investment of $1.67 million to fund 26 recipients of our CIHR New Investigator Grants in Maternal, Reproductive, Child and Youth Health (2017). We would also like to say thank you to the applicants’ funding partners who made this opportunity possible by providing matched funding.
“Early career investigators are the future of our health research enterprise. This initiative will help support those working in maternal, reproductive, child and youth health research with the aim of ensuring that Canada continues to be a leader in the field in the coming years.”
The funded early career investigators will conduct research across the four CIHR pillars (biomedical, clinical, health systems services, and population health) that has the potential to have a significant impact on maternal, reproductive, child and youth health outcomes.
Examples of the CIHR New Investigators in Maternal, Reproductive, Child and Youth Health funded by each participating CIHR Institute include:
- IAPH: Dr. Jennifer Leason at the University of Calgary, who will be creating and piloting an Indigenous Maternity Experiences Survey to identify the unique and complex context of Indigenous women’s maternity experiences;
- ICR: Dr. Amit Bhavsar at the University of Alberta, who will be identifying how to predict and prevent adverse drug reactions associated with the use of cisplatin in childhood cancer treatment by using pharmacogenomics;
- ICRH: Dr. Stephen Renaud at the University of Western Ontario, who will be studying the role of immune cells in the uterus in regulating placental blood flow and fetal health;
- IHDCYH: Dr. Marie Brossard-Racine at the Montreal Children's Hospital Research Institute, who will be assessing how the brain grows and adapts during the first year following very preterm birth;
- IMHA: Dr. Hugh Kim at the University of British Columbia, who will be focusing on platelet signaling to identify novel biomarkers for juvenile arthritis;
- INMHA: Dr. Tuong-Vi Nguyen at McGill University, who will be investigating how pre-conception and perinatal paternal factors contribute to children’s brain and endocrine development up to 8 years of age; and
- INMD: Dr. Ryan Van Lieshout at McMaster University who will be studying intellectual and emotional development in children of women who took part in a structured and monitored nutrition and exercise program while they were pregnant.
- Date modified: